Choi, J H
Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB. [electronic resource]
- Inflammation Oct 2000
- 385-98 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 0360-3997
Standard No.: 10.1023/a:1007068010645 doi
Subjects--Topical Terms: Acetylcysteine--pharmacology Animals Antioxidants--pharmacology Azepines--pharmacology Benzoquinones DNA-Binding Proteins--metabolism Disseminated Intravascular Coagulation--chemically induced Female Gene Expression Regulation--drug effects Genistein--pharmacology Hemorrhage--chemically induced Hydrogen Peroxide--pharmacology I-kappa B Proteins Isoflavones--pharmacology Kidney Medulla--blood supply Lactams, Macrocyclic Lethal Dose 50 Macrophages--drug effects Mice Mice, Inbred C57BL NF-KappaB Inhibitor alpha NF-kappa B--metabolism Phosphorylation Platelet Activating Factor--antagonists & inhibitors Protein Processing, Post-Translational Protein-Tyrosine Kinases--physiology Pulmonary Edema--chemically induced Pyrrolidines--pharmacology Quinones--pharmacology Reactive Oxygen Species--metabolism Rifabutin--analogs & derivatives Serine Proteinase Inhibitors--pharmacology Signal Transduction--drug effects Specific Pathogen-Free Organisms Succinic Acid--pharmacology Thiocarbamates--pharmacology Tosylphenylalanyl Chloromethyl Ketone--pharmacology Triazoles--pharmacology Tumor Necrosis Factor-alpha--biosynthesis Vitamin E--pharmacology